z-logo
open-access-imgOpen Access
Clinical Characteristics and Long-term Follow-up of Patients with Diabetes Due To PTF1A Enhancer Mutations
Author(s) -
Hüseyin Demirbilek,
Atilla Çayır,
Sarah E. Flanagan,
Ruken Yıldırım,
Yılmaz Kör,
Fatih Gürbüz,
Belma Haliloğlu,
Melek Yıldız,
Rıza Taner Baran,
Emine Demet Akbaş,
Meliha Demiral,
Edip Ünal,
Gülçin Arslan,
Doğuş Vurallı,
Gönül Büyükyılmaz,
Sara AlKhawaga,
Amira Saeed,
Maryam Al Maadheed,
Amel Khalifa,
Hasan Önal,
Bilgin Yüksel,
Mehmet Nuri Özbek,
Abdullah Bereket,
Andrew T. Hattersley,
Khalid Hussain,
Elisa De Franco
Publication year - 2020
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/clinem/dgaa613
Subject(s) - medicine , diabetes mellitus , gastroenterology , pediatrics , endocrinology , glycated hemoglobin , type 2 diabetes
Biallelic mutations in the PTF1A enhancer are the commonest cause of isolated pancreatic agenesis. These patients do not have severe neurological features associated with loss-of-function PTF1A mutations. Their clinical phenotype and disease progression have not been well characterized.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom